Neurological Disorders and Stroke

Deborah Zelinsky, O.D., F.N.O.R.A., F.C.O.V.D. is the executive director of the Mind-Eye Institute, an organization dedicated to bridging the gap between 21st century neuroscience discoveries and 20th century methods of eyecare diagnosis and treatment. During the past thirty years, she has developed methods to assess brain function, testing the overlooked linkage between eyes and ears. She is a frequent grant reviewer and consults internationally. She also presents workshops discussing how the retina is comprised of brain tissue. In 2013, she was presented with the Neuro-Optometric Rehabilitation Association’s Founding Father’s Award. Along with Donalee Markus, Ph.D, Dr. Zelinsky is featured in the 2015 book “The Ghost in My Brain: How a Concussion Stole My Life and the New Science of Brain Plasticity Brought it Back” by Dr. Clark Elliott. She is also cited in the afterword of Norman Doidge’s 2016 paperback New York Times Best Seller, “The Brain’s Way of Healing.”

Deborah Zelinsky, O.D., F.N.O.R.A., F.C.O.V.D. is the executive director of the Mind-Eye Institute, an organization dedicated to bridging the gap between 21st century neuroscience discoveries and 20th century methods of eyecare diagnosis and treatment. During the past thirty years, she has developed methods to assess brain function, testing the overlooked linkage between eyes and ears. She is a frequent grant reviewer and consults internationally. She also presents workshops discussing how the retina is comprised of brain tissue. In 2013, she was presented with the Neuro-Optometric Rehabilitation Association’s Founding Father’s Award. Along with Donalee Markus, Ph.D, Dr. Zelinsky is featured in the 2015 book “The Ghost in My Brain: How a Concussion Stole My Life and the New Science of Brain Plasticity Brought it Back” by Dr. Clark Elliott. She is also cited in the afterword of Norman Doidge’s 2016 paperback New York Times Best Seller, “The Brain’s Way of Healing.”

The author received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010 to 2013, then conducted his own diabetes research during 2014 to 2018. His approach is “quantitative medicine” based on mathematics, physics, optical and electronics physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and artificial intelligence. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.

The author received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010 to 2013, then conducted his own diabetes research during 2014 to 2018. His approach is “quantitative medicine” based on mathematics, physics, optical and electronics physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and artificial intelligence. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.

Dr. Romario M. Ramos is a neurologist, psychiatrist and psychologist. He is a fellow of the Philippine Neurological Association (PNA), the Cluster Head and Disaster Preparedness Team Head of Mindoro of the PNA Southern Luzon Chapter and a member of the Advocacy Committee of the PNA. He is the Head of Section of Neurology at the Medical Mission Group Hospital Multipurpose Cooperative of Oriental Mindoro (MMGHMCOM). He is a member of the Oriental Mindoro Medical Society (OMMS), Wellness Committee of the Society of Vascular and Interventional Neurology (SVIN) and Digital Transformation Leadership Working Group of the International Society for Telemedicine and eHealth (ISfTeH).

Dr. Romario M. Ramos is a neurologist, psychiatrist and psychologist. He is a fellow of the Philippine Neurological Association (PNA), the Cluster Head and Disaster Preparedness Team Head of Mindoro of the PNA Southern Luzon Chapter and a member of the Advocacy Committee of the PNA. He is the Head of Section of Neurology at the Medical Mission Group Hospital Multipurpose Cooperative of Oriental Mindoro (MMGHMCOM). He is a member of the Oriental Mindoro Medical Society (OMMS), Wellness Committee of the Society of Vascular and Interventional Neurology (SVIN) and Digital Transformation Leadership Working Group of the International Society for Telemedicine and eHealth (ISfTeH).

Laura Cancedda graduated in Medicinal Chemistry at the University of Genoa in 1999, with a thesis on the role of neurotrophic factors on neurotransmitter release. She received her Ph.D. in neurophysiology from Scuola Normale Superiore (Pisa, Italy) in 2003, under the supervision of Dr Maffei. In Pisa, she investigated the molecular and environmental basis of experience-dependent plasticity in the rat brain. In 2003, she moved to University of California at Berkeley in Dr Poo’s laboratory where she focused her studies on molecular mechanisms of GABAergic-transmission modulation. Currently, she holds a team-leader position at the Italian Institute of Technology (IIT) in Genoa (2008- ) and a scientist position at the Telethon Dulbecco Institute, Italy (2016- ). Her research focuses on the role of extracellular factors in migration, morphological maturation and wiring of cortical neurons under physiological as well as pathological conditions. Laura has also an interest in investigating new approaches for in vivo transfection of nucleic acids

Laura Cancedda graduated in Medicinal Chemistry at the University of Genoa in 1999, with a thesis on the role of neurotrophic factors on neurotransmitter release. She received her Ph.D. in neurophysiology from Scuola Normale Superiore (Pisa, Italy) in 2003, under the supervision of Dr Maffei. In Pisa, she investigated the molecular and environmental basis of experience-dependent plasticity in the rat brain. In 2003, she moved to University of California at Berkeley in Dr Poo’s laboratory where she focused her studies on molecular mechanisms of GABAergic-transmission modulation. Currently, she holds a team-leader position at the Italian Institute of Technology (IIT) in Genoa (2008- ) and a scientist position at the Telethon Dulbecco Institute, Italy (2016- ). Her research focuses on the role of extracellular factors in migration, morphological maturation and wiring of cortical neurons under physiological as well as pathological conditions. Laura has also an interest in investigating new approaches for in vivo transfection of nucleic acids

Dr. Tezapsidis is the founder of Neurotez, Inc. and has been the President, Chief Executive Officer and Chairman of the Board of Directors since the company was incorporated in 2005. Nikolaos raised funds through non-dilutive capital sources while building the company, recruiting top talent, maintaining top notch research and development programs and establishing a strong patent portfolio. A few years ago he negotiated a milestone-linked $100 million deal exclusive for China and a partnership with Memtrax for a new memory screening test for Alzheimer’s patients. Currently Neurotez is raising funds for clinical trials testing leptin to treat Alzheimer’s. Recipient of two awards from the Alzheimer’s Association, USA and fellowships from the Wellcome Trust and the Science and Engineering Council, UK. He has several patents issued and pending both in the US and in foreign markets and is the author of more than fifty publications. Dr. Tezapsidis received a Bachelor of Science in Chemistry from the Aristotle University, Greece and completed his Master of Science and Doctor of Philosophy in Biochemistry at the University of Sussex, UK. Nik has been interviewed by The National Herald (http://www.thenationalherald.com/?s=tezapsidis), BioCenturyTV, 1800LiveRadioInterview, and Ellines (https://www.ellines.com/en/category/famous-greeks/ ).

Alzheimer’s ,obesity and/or the metabolic syndrome that modulate brain aging...

Dr. George Perry is currently the dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. After graduation in Zoology from University of California, Santa Barbara, he headed to Scripps Institution of Oceanography and also studied at Hopkins Marine Station of Stanford University and the Marine Biological Laboratory of Woods Hole and obtained his PhD in Marine Biology in 1979. Dr. Perry joined the faculty of Case Western Reserve University in 1995, where he currently holds an adjunct appointment. He is a Fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Medicine, Royal Society of Chemistry, Society of Biology and the Linnean Society and past-president of the American Association of Neuropathologists. He has been elected member of the Spanish Royal Academy of Sciences, Mexican Academy of Sciences and Academy of Sciences Lisbon; Iberoamerican Molecular Biology Organization, Dana Alliance for Brain Initiatives and won the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native Americans in Science, Senior Investigator Award from the International College of Geriatric psychoneuropharmacology, Senior Fulbright Fellow and the National Honor Plaque of Panama for exceptional contributions to Neuroscience. Dr. Perry is on Board of the National Organization of Portuguese Americans and serves as Director of Education and Research.

Dr. George Perry is currently the dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. After graduation in Zoology from University of California, Santa Barbara, he headed to Scripps Institution of Oceanography and also studied at Hopkins Marine Station of Stanford University and the Marine Biological Laboratory of Woods Hole and obtained his PhD in Marine Biology in 1979. Dr. Perry joined the faculty of Case Western Reserve University in 1995, where he currently holds an adjunct appointment. He is a Fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Medicine, Royal Society of Chemistry, Society of Biology and the Linnean Society and past-president of the American Association of Neuropathologists. He has been elected member of the Spanish Royal Academy of Sciences, Mexican Academy of Sciences and Academy of Sciences Lisbon; Iberoamerican Molecular Biology Organization, Dana Alliance for Brain Initiatives and won the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native Americans in Science, Senior Investigator Award from the International College of Geriatric psychoneuropharmacology, Senior Fulbright Fellow and the National Honor Plaque of Panama for exceptional contributions to Neuroscience. Dr. Perry is on Board of the National Organization of Portuguese Americans and serves as Director of Education and Research.